×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/20
07:29 am
cdna
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing [Yahoo! Finance]
Low
Report
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing [Yahoo! Finance]
4/20
07:05 am
cdna
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
Low
Report
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
4/19
10:43 pm
cdna
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns [Yahoo! Finance]
Low
Report
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns [Yahoo! Finance]
4/18
08:17 am
cdna
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results [Seeking Alpha]
Low
Report
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results [Seeking Alpha]
4/15
05:30 pm
cdna
Stocks to watch after market on Wednesday: CDNA, JBHT, SLG, QDEL [Seeking Alpha]
High
Report
Stocks to watch after market on Wednesday: CDNA, JBHT, SLG, QDEL [Seeking Alpha]
4/15
04:30 pm
cdna
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
High
Report
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
4/14
04:41 pm
cdna
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 [Yahoo! Finance]
Low
Report
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 [Yahoo! Finance]
4/14
04:01 pm
cdna
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
Low
Report
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
04:12 pm
cdna
Form 144 CareDx, Inc. Filed by: Hanna John Walter JR
Medium
Report
Form 144 CareDx, Inc. Filed by: Hanna John Walter JR
4/16
04:05 pm
cdna
Form 4 CareDx, Inc. For: Apr 15 Filed by: Hanna John Walter JR
Medium
Report
Form 4 CareDx, Inc. For: Apr 15 Filed by: Hanna John Walter JR
4/16
06:06 am
cdna
Form 8-K CareDx, Inc. For: Apr 15
High
Report
Form 8-K CareDx, Inc. For: Apr 15
4/7
04:01 pm
cdna
Form 4 CareDx, Inc. For: Apr 06 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Apr 06 Filed by: Novack Jeffrey Adam
4/3
04:05 pm
cdna
Form 4 CareDx, Inc. For: Apr 01 Filed by: Hanna John Walter JR
Low
Report
Form 4 CareDx, Inc. For: Apr 01 Filed by: Hanna John Walter JR
4/3
04:04 pm
cdna
Form 4 CareDx, Inc. For: Apr 01 Filed by: Kennedy Keith
Low
Report
Form 4 CareDx, Inc. For: Apr 01 Filed by: Kennedy Keith
4/3
04:04 pm
cdna
Form 4 CareDx, Inc. For: Apr 01 Filed by: Meng Jessica
Low
Report
Form 4 CareDx, Inc. For: Apr 01 Filed by: Meng Jessica
4/3
04:03 pm
cdna
Form 4 CareDx, Inc. For: Apr 01 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Apr 01 Filed by: Novack Jeffrey Adam
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: